
Jing Zhu
Articles
-
3 days ago |
outsourcedpharma.com | Xiaojun Liu |Yeonji Kim |Chris Brown |Jing Zhu |Louis Garguilo
By Xiaojun Liu, Yeonji Kim, Chris Brown, and Jing Zhu Recombinant adeno-associated virus (rAAV) vectors are pivotal in gene therapy due to their proven safety and efficacy for therapeutic gene delivery. However, low production yields and vector heterogeneity remain significant barriers to scalable, high-quality manufacturing.
-
3 days ago |
cellandgene.com | Xiaojun Liu |Yeonji Kim |Chris Brown |Jing Zhu
By Xiaojun Liu, Yeonji Kim, Chris Brown, and Jing Zhu Recombinant adeno-associated virus (rAAV) vectors are pivotal in gene therapy due to their proven safety and efficacy for therapeutic gene delivery. However, low production yields and vector heterogeneity remain significant barriers to scalable, high-quality manufacturing.
-
Jan 30, 2025 |
advanced.onlinelibrary.wiley.com | Yu Tang |Rui Liu |Jing Zhu |Qian He
1 Introduction Breast cancer (BC) is the most prevalent malignant tumor in women globally and one of the major causes of cancer-related death in women.[1] Breast cancer is divided into four subtypes based on IHC results for estrogen receptor (ERα), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), and the tumor cell proliferation index (Ki-67):[2] Luminal A, Luminal B, HER2 positive and basal-like breast cancer (BLBC).
-
Nov 10, 2024 |
nature.com | Jing Zhu
AbstractEndoscopic bariatric surgery (EBS) is a new treatment for obesity. We compared the efficacy, safety, and probability of metabolic complications of different EBSs with laparoscopic sleeve gastrectomy (LSG). This systematic review and network meta-analysis (NMA) included searches of PubMed, Web of Science, and the Cochrane Library from January 1, 2017, to December 27, 2022, to find comparative trials of EBS procedures and EBS with LSG.
-
Aug 20, 2024 |
onlinelibrary.wiley.com | Chenyang Li |Lili Sun |Jing Zhu |Xin Wang
DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →